- Home
- BBIO vs CMA Comparison
BBIO vs CMA Comparison
Compare BBIO & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- CMA
- Stock Information
- Founded
- BBIO 2015
- CMA 1849
- Country
- BBIO United States
- CMA United States
- Employees
- BBIO N/A
- CMA N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- CMA Major Banks
- Sector
- BBIO Health Care
- CMA Finance
- Exchange
- BBIO Nasdaq
- CMA Nasdaq
- Market Cap
- BBIO 8.0B
- CMA 7.7B
- IPO Year
- BBIO 2019
- CMA N/A
- Fundamental
- Price
- BBIO $45.12
- CMA $59.81
- Analyst Decision
- BBIO Strong Buy
- CMA Hold
- Analyst Count
- BBIO 14
- CMA 20
- Target Price
- BBIO $58.85
- CMA $61.15
- AVG Volume (30 Days)
- BBIO 3.3M
- CMA 1.3M
- Earning Date
- BBIO 07-31-2025
- CMA 07-18-2025
- Dividend Yield
- BBIO N/A
- CMA 4.76%
- EPS Growth
- BBIO N/A
- CMA 4.95
- EPS
- BBIO N/A
- CMA 5.29
- Revenue
- BBIO $127,415,000.00
- CMA $3,234,000,000.00
- Revenue This Year
- BBIO $102.05
- CMA $7.20
- Revenue Next Year
- BBIO $54.69
- CMA $3.01
- P/E Ratio
- BBIO N/A
- CMA $11.29
- Revenue Growth
- BBIO N/A
- CMA N/A
- 52 Week Low
- BBIO $21.72
- CMA $48.12
- 52 Week High
- BBIO $45.48
- CMA $73.45
- Technical
- Relative Strength Index (RSI)
- BBIO 77.53
- CMA 59.93
- Support Level
- BBIO $39.65
- CMA $57.53
- Resistance Level
- BBIO $45.18
- CMA $58.73
- Average True Range (ATR)
- BBIO 1.49
- CMA 1.07
- MACD
- BBIO 0.54
- CMA 0.14
- Stochastic Oscillator
- BBIO 99.13
- CMA 94.00
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.